Vistagen Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vistagen Therapeutics Inc
TickerVTGN
CIK #0001411685
CUSIP92840H400
SectorLife Sciences - Pharmaceutical Preparations
Address384 Oyster Point Boulevard, No 8, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001411685] 10-K
[0001411685] 10-Q
[0001411685] 3
[0001411685] 4
[0001411685] 8-K
[0001411685] D
[0001411685] SC 13D
[0001411685] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Nantahala Capital Management LLC Vistagen Therapeutics Inc [2024-02-14] 0.9
Vanguard Group Inc Vistagen Therapeutics Inc [2024-02-13] 6.79
Stempoint Capital LP Vistagen Therapeutics Inc [2024-02-12] 0.0
TCG Crossover GP II LLC Vistagen Therapeutics Inc [2023-10-16] 81947.5
Biotechnology Value Fund L P Vistagen Therapeutics Inc [2023-10-16] 5.2
Citadel Advisors LLC Vistagen Therapeutics Inc [2023-10-16] 5.6
Great Point Partners LLC Vistagen Therapeutics Inc [2023-10-12] 0.99
Point72 Asset Management LP Vistagen Therapeutics Inc [2023-10-05] 5.6
Commodore Capital LP Vistagen Therapeutics Inc [2023-08-09] 19.7
Commodore Capital LP Vistagen Therapeutics Inc [2022-04-14] 5.1
Franklin Resources Inc Vistagen Therapeutics Inc [2022-02-04] 5.1
BlackRock Inc Vistagen Therapeutics Inc [2022-02-04] 6.0
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-03-22] 8.4
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-02-16] 5.4
Venrock Healthcare Capital Partners II LP Vistagen Therapeutics Inc [2021-02-16] 0.99
OrbiMed Advisors LLC Vistagen Therapeutics Inc [2021-02-12] 6.9
Growth Equity Opportunities 17 LLC Vistagen Therapeutics Inc [2021-01-04] 6.8
Rosalind Advisors Inc Vistagen Therapeutics Inc [2020-09-18] 5.4
Lincoln Park Capital Fund LLC Vistagen Therapeutics Inc [2020-01-29] 0.62
Pherin Pharmaceuticals Inc Vistagen Therapeutics Inc [2019-03-08] 8.2
CVI Investments Inc Vistagen Therapeutics Inc [2017-12-20] 6.1
Intracoastal Capital LLC Vistagen Therapeutics Inc [2017-12-20] 0.99
Sabby Management LLC Vistagen Therapeutics Inc [2017-12-14] 0.15
Sphera Funds Management Ltd Vistagen Therapeutics Inc [2016-06-22] 7.63
Empery Asset Management LP Vistagen Therapeutics Inc [2016-05-19] 0.87
Sabby Management LLC Vistagen Therapeutics Inc [2016-05-13] 6.56
Nexthera Capital LP Vistagen Therapeutics Inc [2016-02-29] 5.3
Calm SEAS Capital LLC Vistagen Therapeutics Inc [2016-02-05] 5.87
Form 3/4/5 Filer 2011 - 2025
Anderson Cynthia Lynn
Vistagen Therapeutics, Inc.
Prince Joshua S.
Adler Reid G.
Singh Shawn
Cote Elissa S.
FitzPatrick Margaret M
GIN Jerry B
Curley Joanne
Cunningham Ann Michelle
Rotunno Mary L.
SAXE Jon S
Commodore Capital LP
Dotson Jerrold Duane
Smith Mark Alan
Shah Nimish P
VHCP Co-Investment Holdings II, LLC
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Management II, LLC
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
Venrock Healthcare Capital Partners EG, L.P.
Venrock Healthcare Capital Partners II, L.P.
Snodgrass H Ralph
Underdown Brian J.
Ginski Mark J
McPartland Mark A
Rice A Franklin
Bonfiglio Gregory A.
Cato Allen Easley
Cato Holding Co
Form 13F Holdings
Firm Period DFND Voting Shares
TCG Crossover Management LLC [2025-06-30] SOLE 2,676,580 2,676,580
Stempoint Capital LP [2025-06-30] SOLE 2,137,168 2,413,254
Nantahala Capital Management LLC [2025-06-30] SOLE 1,978,492 1,978,492
Vanguard Group Inc [2025-06-30] SOLE 0 1,748,833
Commodore Capital LP [2025-06-30] SOLE 1,575,000 1,575,000
JPMorgan Chase & Co [2025-06-30] DFND 748,862 748,862
Ikarian Capital LLC [2025-06-30] SOLE 601,703 601,703
Sphera Funds Management Ltd [2025-06-30] DFND 447,939 447,939
Adar1 Capital Management LLC [2025-06-30] SOLE 420,765 420,765
BlackRock, Inc. [2025-06-30] SOLE 416,889 416,889
Diadema Partners LP [2025-06-30] SOLE 404,122 404,122
Geode Capital Management LLC [2025-06-30] DFND 272,907 272,907
Almitas Capital LLC [2025-06-30] SOLE 261,399 261,399
Advisorshares Investments LLC [2025-06-30] SOLE 203,114 203,114
Boothbay Fund Management LLC [2025-06-30] OTR 0 177,858
BML Capital Management LLC [2025-06-30] SOLE 0 150,000
Susquehanna International Group LLP [2025-06-30] OTR 115,368 115,368
Citadel Advisors LLC [2025-06-30] DFND 103,000 103,000
State Street Corp [2025-06-30] DFND 96,858 96,858
Jane Street Group LLC [2025-06-30] DFND 95,051 95,051
Two Sigma Investments LP [2025-06-30] SOLE 89,451 89,451
Persistent Asset Partners Ltd [2025-06-30] SOLE 86,819 86,819
Blair William & Co/IL [2025-06-30] SOLE 85,866 85,866
Northern Trust Corp [2025-06-30] DFND 48,093 48,093
Dimensional Fund Advisors LP [2025-06-30] SOLE 43,362 43,362
Renaissance Technologies LLC [2025-06-30] SOLE 40,500 40,500
Marshall Wace LLP [2025-06-30] OTR 0 34,638
American Century Companies Inc [2025-06-30] DFND 31,063 31,063
Two Sigma Advisers LP [2025-06-30] SOLE 24,991 25,832
Charles Schwab Investment Management Inc [2025-06-30] SOLE 23,302 23,302
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com